Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.14743 | 6 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.1312 | 6 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.13279 | 6 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.07811 | 6 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.07348 | 6 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.18469 | 7 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.1292 | 6 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.10884 | 6 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.09654 | 6 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.11864 | 6 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.11516 | 6 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.10145 | 6 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.12412 | 6 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.12021 | 6 |